MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Impaired topographic organization in cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson’s disease

    Y.B. Hou, Q.Q. Wei, R.W. Ou, J. Yang, W. Song, Q.Y. Gong, H.F. Shang (Chengdu, People’s Republic of China)

    Objective: To investigate the disrupted topographic organization in a cohort of cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson’s disease (PDAR), and its potential relationships with…
  • 2018 International Congress

    Study on feasibility to develop a central nervous system (CNS) Leucine-rich repeat kinase 2 (LRRK2) PET tracer

    Z. Zeng, P. Miller, T. Graham, L. Tong, D. Hesk, W. Li, E. Hostetler (West Point, PA, USA)

    Objective: To assess feasibility of developing a CNS LRRK2 PET tracer. Background: LRRK2 enzyme belongs to the leucine-rich repeat kinase family. Pathogenic mutations in the…
  • 2018 International Congress

    Potential indicator of antiparkinsonian drug efficacy: an attempt to explore imaging findings

    S. Taguchi, N. Tanabe, H. Oiwa, M. Hayashi, C. Nagatomi, S. Saeki, K. Nakashima, T. Yuasa, A. Yasumoto, H. Ando, T. Higa, A. Fujikake, T. Fukuoka, K. TokuI, Y. Okada, J. Niwa, M. Izumi, N. Nakao, M. Doyu (Nagakute, Japan)

    Objective: To clarify the Single photon emission computed tomography (SPECT) findings for evaluating currently unknown antiparkinsonian drug efficacy in Parkinson’s disease (PD) patients. Background: Little…
  • 2018 International Congress

    Semi-automated segmentation and quantification of the substantia nigra depigmentation in Parkinson’s disease – a multicentre case control MRI study in 284 participants

    Y. Xing, S. Schwarz, A. Martin-Bastida, L. Parkes, H. Abdul-Sapuan, S. Naidu, M. Silverdale, D. Grosset, P. Piccini, D. Burn, N. Bajaj, N. Pavese, D. Auer (Nottingham, United Kingdom)

    Objective: To provide a semi-automated segmentation and quantification method of the changes in the substantia nigra (SN) in Parkinson’s disease (PD) using neuromelanin (NM)-sensitive MRI…
  • 2018 International Congress

    Alterations of cortical metabotropic glutamate receptor-mediated signaling in patients with Parkinson’s disease

    JY. Lee, YK. Kim, SA. Shin, SH. Seo, JS. Lee, YS. Lee, JM. Jeong, B. Jeon (Seoul, Republic of Korea)

    Objective: To evaluate expression of brain metabotropic glutamatergic receptor 5 and the relationship with clinical measures in Parkinson’s disease patients. Background: Metabotropic glutamate receptor 5…
  • 2018 International Congress

    Dopaminergic and Metabolic Imaging in Parkinson’s Disease motor subtypes and their relations to parkinsonian tremor

    J. Zhao, L. Li, P. Wu, J. Wang, C.T. Zuo (Shanghai, China)

    Objective: The mechanism underlying rest tremor of Parkinson’s disease(PD), while likely differing from those underlying akinesia and rigidity, remains unclear. The objective of this study…
  • 2018 International Congress

    Effects of age, motor severity and disease duration on finger tapping movement under dual-task in Parkinson’s disease patients

    A. Miyake, T. Yamamoto, H. Kawasaki, N. Tamura, N. Araki (Saitama prefecture, Japan)

    Objective: Twenty-six patients with Parkinson's disease (PD) (68.0 ± 8.0 years old; mean ±SD) underwent finger tapping (FT) on the symptom-predominant side during pronation-supination movement…
  • 2018 International Congress

    Brain network activation (BNA): A new biomarker for Parkinson’s disease?

    S. Hassin-Baer, Z. Pereman, R. Yahav, S. Israeli-Korn, G. Yahalom, S. Benizri, R. Shani-Hershkovich, G. Issachar, A. Geva, O. Cohen (Ramat Gan, Israel)

    Objective: We aimed to assess the ability of the Brain Network Activation (BNA) EEG analysis algorithm to differentiate between early-stage Parkinson’s disease (PD) patients and…
  • 2018 International Congress

    What happens when I watch a ballet? Preliminary fMRI findings on somatosensory empathy in Parkinson Disease

    S. Palermo, R. Morese, M. Zibetti, M. Stanziano, A. Pontremoli, A. Romagnolo, G. Carlotti, A. Zardi, M. Valentini, L. Lopiano (Turin, Italy)

    Objective: To investigate the neural components of the mirror sensor-motor system recruited by a dance movement in a motor disorder, such as PD is. Background:…
  • 2018 International Congress

    Remote patient monitoring with a digital biomarker approach generates clinically distinctive and meaningful sensor feature data in Parkinson’s disease: Differential relationships with MDS-UPDRS-III, PDQ-39 and DaT-SPECT

    F. Lipsmeier, K. Taylor, R. Postuma, D. Wolf, T. Kilchenmann, A. Scotland, J. Schjodt-Erkisen, W. Cheng, J. Siebourg-Polster, L. Jin, J. Soto, L. Verselis, F. Boess, M. Koller, M. Grundman, T. Kremer, C. Czech, C. Gossens, M. Lindemann (Basel, Switzerland)

    Objective: To determine whether sensor features derived from remote smartphone testing in Parkinson’s disease (PD) predicted clinical, quality of life and biomarker measures collected in…
  • « Previous Page
  • 1
  • …
  • 1337
  • 1338
  • 1339
  • 1340
  • 1341
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley